IS5240A - Sulfate salt of HIV protease inhibitor that has improved oral and biological uptake - Google Patents

Sulfate salt of HIV protease inhibitor that has improved oral and biological uptake

Info

Publication number
IS5240A
IS5240A IS5240A IS5240A IS5240A IS 5240 A IS5240 A IS 5240A IS 5240 A IS5240 A IS 5240A IS 5240 A IS5240 A IS 5240A IS 5240 A IS5240 A IS 5240A
Authority
IS
Iceland
Prior art keywords
protease inhibitor
hiv protease
sulfate salt
improved oral
biological uptake
Prior art date
Application number
IS5240A
Other languages
Icelandic (is)
Inventor
Askin David
R. Hoerrner Scott
M. Purick Robert
Reider Paul
J. Varsolona Richard
P. Volante Ralph
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9714320.0A external-priority patent/GB9714320D0/en
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of IS5240A publication Critical patent/IS5240A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS5240A 1997-05-29 1999-11-09 Sulfate salt of HIV protease inhibitor that has improved oral and biological uptake IS5240A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4795097P 1997-05-29 1997-05-29
GBGB9714320.0A GB9714320D0 (en) 1997-07-07 1997-07-07 Hiv protease inhibitor
PCT/US1998/010633 WO1998054178A1 (en) 1997-05-29 1998-05-26 Sulfate salt of an hiv protease inhibitor having an improved oral absorption and bioavailability

Publications (1)

Publication Number Publication Date
IS5240A true IS5240A (en) 1999-11-09

Family

ID=26311845

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5240A IS5240A (en) 1997-05-29 1999-11-09 Sulfate salt of HIV protease inhibitor that has improved oral and biological uptake

Country Status (22)

Country Link
EP (1) EP0986554A1 (en)
JP (1) JP3267632B2 (en)
KR (1) KR20010013042A (en)
CN (1) CN1257497A (en)
AU (1) AU730245B2 (en)
BG (1) BG103923A (en)
BR (1) BR9809498A (en)
CA (1) CA2291086A1 (en)
EA (1) EA199901095A1 (en)
EE (1) EE9900543A (en)
HR (1) HRP980283A2 (en)
HU (1) HUP0004621A3 (en)
ID (1) ID23858A (en)
IL (1) IL132779A0 (en)
IS (1) IS5240A (en)
NO (1) NO995822L (en)
PE (1) PE75099A1 (en)
PL (1) PL336847A1 (en)
SK (1) SK163299A3 (en)
TR (1) TR199902816T2 (en)
TW (1) TW438799B (en)
WO (1) WO1998054178A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003514910A (en) 1999-11-24 2003-04-22 メルク エンド カムパニー インコーポレーテッド Gamma-hydroxy-2- (fluoroalkylaminocarbonyl) -1-piperazinepentanamides as HIV protease inhibitors
US20020082421A1 (en) * 2000-09-14 2002-06-27 Abdel-Magid Ahmed F. Novel solid salt forms of N-[2-[4-[2-(1- methylethoxy)phenyl]-1-piperazinyl]-2-oxo-1piperidineacetamide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0734387B1 (en) * 1993-12-15 2002-04-10 Merck & Co. Inc. Hiv protease inhibitors

Also Published As

Publication number Publication date
EP0986554A1 (en) 2000-03-22
KR20010013042A (en) 2001-02-26
HRP980283A2 (en) 1999-08-31
BG103923A (en) 2000-06-30
HUP0004621A3 (en) 2002-04-29
EA199901095A1 (en) 2000-08-28
EE9900543A (en) 2000-06-15
AU7595998A (en) 1998-12-30
WO1998054178A1 (en) 1998-12-03
CN1257497A (en) 2000-06-21
IL132779A0 (en) 2001-03-19
JP3267632B2 (en) 2002-03-18
NO995822L (en) 2000-01-28
TR199902816T2 (en) 2000-02-21
JP2000513747A (en) 2000-10-17
TW438799B (en) 2001-06-07
CA2291086A1 (en) 1998-12-03
ID23858A (en) 2000-05-25
SK163299A3 (en) 2000-07-11
PL336847A1 (en) 2000-07-17
PE75099A1 (en) 1999-08-11
BR9809498A (en) 2000-06-20
NO995822D0 (en) 1999-11-26
HUP0004621A2 (en) 2002-03-28
AU730245B2 (en) 2001-03-01

Similar Documents

Publication Publication Date Title
SG80631A1 (en) Inhibitors of hiv reverse transcriptase
DE69835913D1 (en) Aspartate proteinase 2 (ASP2)
IL146904A0 (en) Gypsum compositions and related methods
DK1064298T3 (en) Inhibitors of caspases
IL137384A0 (en) Bisulfate salt of hiv protease inhibitor
CY2006003I1 (en) USE OF DAPTOMYCIN
IS4928A (en) Phosphine-linked inhibitors of metal protease lattices
EP1423399A4 (en) Hydroxypyridonate and hydroxypyrimidinone chelating agents
NO20032753L (en) Compound and Use thereof
DE60136181D1 (en) 3'-PRODRUGS OF 2'-DEOXY-BETA-L-NUCLEOSIDES
IL151617A0 (en) Improved gunsight and reticle therefor
DK2028186T3 (en) Hepatitis C inhibitor tripeptides
PT1139761E (en) HERBICID AND CONCENTRATED COMPOSITIONS
IS5302A (en) New amidino derivatives and their use as thrombin inhibitors
ID23610A (en) SHIFTING TOOLS THAT CAN BE DEVELOPED
ID18417A (en) INHIBITOR DENTAL METALOPROTEASE
IS5240A (en) Sulfate salt of HIV protease inhibitor that has improved oral and biological uptake
SG119168A1 (en) Utilization of at least one aminopeptidase inhibitor
DK1015419T3 (en) Polydentate imines and their metal complexes
IS5155A (en) Multiple copolymers of zopololestat monohydrate
NO20025135D0 (en) Antihypertensive agents and use
GB0021921D0 (en) Kit of adhesion-release agents
LV12052A (en) Saturation of filigree spatial metallic inputs
GB9806144D0 (en) Jigsaw puzzle of simple construction
DE29815341U1 (en) Multi-piece piece of jewelry